Stay updated with breaking news from Tprds. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Foresite Capital Management V LLC increased its stake in Pardes Biosciences, Inc. (NASDAQ:PRDS – Get Rating) by 6.8% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 10,037,935 shares of the company’s stock after purchasing an additional 637,420 shares during the period. Pardes […]
Pardes Biosciences (NASDAQ:PRDS – Get Rating) and Decibel Therapeutics (NASDAQ:DBTX – Get Rating) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their dividends, valuation, profitability, institutional ownership, risk, analyst recommendations and earnings. Profitability This table compares Pardes Biosciences and Decibel Therapeutics’ […]
Pardes Biosciences, Inc. (NASDAQ:PRDS – Get Rating) saw a large drop in short interest in the month of March. As of March 31st, there was short interest totalling 2,010,000 shares, a drop of 29.2% from the March 15th total of 2,840,000 shares. Based on an average trading volume of 296,700 shares, the short-interest ratio is […]
Toro 18 increased its stake in Turtle Beach, a maker of gaming and audio accessories. Magnetar Financial disclosed a large stake in Momentive Global, a software-products company.
Pardes Biosciences, Inc. (NASDAQ:PRDS – Get Rating) major shareholder Foresite Capital Opportunity M acquired 773,952 shares of the firm’s stock in a transaction that occurred on Wednesday, April 5th. The stock was acquired at an average cost of $1.50 per share, with a total value of $1,160,928.00. Following the completion of the acquisition, the insider […]